|
![]() ![]() | |||
There is an increasing role for Positron Emission Tomography (PET scan) in the diagnostic evaluation of many types of cancer. This noninvasive technique provides additional information not offered by other diagnostic examinations. PET is also being applied in the neurologic evaluation of seizures and Alzheimer's disease. PET can improve the decision-making process before cardiac surgery in selected patients, as well.
Positron Emission Tomography is chiefly used to provide a map of
glucose use in the various tissues of the body. Glucose is a simple
sugar that is a main energy source for human cells. A modified form
of glucose known as flurodeoxyglucose (FDG) contains a positron
emitter whose energy can be recorded on a crystal outside the
patient. The recorded emissions provide a three-dimensional map of
how glucose is used throughout the body. Cancer cells most often
use glucose more rapidly than normal cells and can be higlighted as
brighter areas on the map.
Conventional cross-sectional imaging studies such as CT, MRI and
ultrasound scans create images of the body's structure and make
pictures of the size and shape of normal and diseased anatomic
structures.
The PET scan provides information about cell function, much different from the structural information provided by conventional imaging studies. "The combination of the anatomic and functional information can be very complementary and powerful in a cancer diagnosis," states radiologist Robert M. Schick, M.D., John Muir Health.
The PET scan requires a fasting, rested individual to receive an
injection of the fluorodeoxyglucose into a small vein in the arm.
During a period of quiet rest, the injected FDG is permitted to
distribute itself within the cells of the body. Patients who are
anxious may ask their physician to provide a preprocedure mild and
short-acting anxiety-relieving medication. There is no sensation
associated with the FDG injection. Following the injection, the
patient lies quietly on a table that moves through a
doughnut-shaped opening, where the information is detected and
recorded. Nothing contacts the patient during this process. The
entire experience takes less than an hour.
Although there are no known harmful effects from the procedure,
there is some radiation exposure associated with the test.
Therefore, it is not performed on pregnant patients or those who
might be pregnant. The radioactive tracer injected for the PET scan
has an extremely short life, changing rapidly to a nonradioactive
and inert material by the time the patient leaves the scanning
facility. As a result, there is no radiation risk for family
members and no restrictions on patient activity following the
scan.
PET scans are helpful in detecting sites of cancer in the lung,
especially in situations where a small shadow of unknown cause is
discovered. In patients with known cancer, a PET scan can provide
more complete information regarding the extent of cancer throughout
the body, permitting improved decision making regarding treatment.
Physicians already incorporate PET scanning into their assessment
strategies for lung cancer, melanoma, colon and rectal cancer, and
lymphoma. "PET promises to be the single most important diagnostic
test for early assessment of a patient's response to chemotherapy.
It will help determine if the chemotherapy is effective or needs to
be supplemented or changed," states radiologist Richard M. Sigel,
M.D., John Muir Health. There is increasing
evidence for the efficacy of PET in evaluating patients with head
and neck cancer, esophageal cancer, ovarian cancer and advanced
breast cancer. PET can also be a problem-solver for patients with
confusing or contradictory results on conventional imaging studies
and can help reduce the need for diagnostic surgical
procedures.
A PET scan of the brain in patients with dementia can differentiate
a typical pattern for Alzheimer's disease from other causes of
premature senility. As treatments improve for Alzheimer's disease,
this diagnostic capability will become increasingly useful. PET can
provide unique information regarding the source of intractable and
disabling seizures in selected patients being considered for
epilepsy surgery. PET can also assist in the selection of patients
for cardiac surgery by most accurately defining the extent of
viable heart muscle.
For the new Spring/Summer resource directory listing information about medical imaging including PET scan services at John Muir Medical Center, Walnut Creek Campus and John Muir Medical Center, Concord Campus, and a variety of other programs and services, call: (925) 947-5384
For a referral to a physician on staff, call John Muir Health Physician Referral Service at (925) 941-2244.